2D grey scale vaginal ultrasound
ProcedureTo assess the endometrial thickness and echogenicity (whether the endometrium is uniform or non-uniform).
NCT Number: NCT02488798
100 patients with postmenopausal bleeding were assessed with 2D vaginal ultrasound and 3D power Doppler ultrasound using the international endometrial tumor analysis group and office hysteroscopy with taking samples for histopathological analysis.
Looking for future studies?
Notify Me47 year–64 year
Female
Observational
The aim was to compare the efficiency of the upper mentioned interventions in diagnosing the cause of postmenopausal bleeding.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
To assess the endometrial thickness and echogenicity (whether the endometrium is uniform or non-uniform).
To assess the endometrium using the IETA group criteria.
using the vaginoscopic approach to assess the uterine cavity and take sample.
Time frame: 1 week
Efficacy of 3D power Doppler ultrasound with the IETA group criteria in diagnosing the cause of postmenopausal bleeding
Cairo University
Other
The Role of Office Hysteroscopy and Endometrial Power Doppler Using the International Endometrial Tumor Analysis Group Classification in the Evaluation of Postmenopausal Bleeding
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07366814
Abnormal Uterine Bleeding, Behavior
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT03382145
Postmenopausal Bleeding
Hong Kong
View Trial DetailsNCT05378152
Endometrial Cancer, Endometrial Hyperplasia
Dublin, Ireland
View Trial DetailsNCT00339651
Disease Attributes, Disease Progression
Hillsboro, Oregon, United States
View Trial Details